Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Lipids containing omega-3 and omega-6 fatty acids

a technology of lipids and omega-3 fatty acids, applied in the field of phospholipids and polar lipid preparations, can solve problems such as cognitive and mental disorders, and achieve the effects of improving attention span, improving memory, and reducing stress and tension

Inactive Publication Date: 2008-04-10
ENZYMOTEC
View PDF9 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The patent text discusses the importance of phospholipids, particularly those containing polyunsaturated fatty acids (PUFAs), in maintaining the fluidity and structure of biological membranes. These phospholipids are essential components of cell membranes and are important for brain function and cognitive health. The patent aims to provide special preparations of PUFA-containing phospholipids for use as nutraceuticals and functional food additives. The technical effects of the patent include improved memory, reduced stress and depression, improved learning capabilities, and improved attention span, among others. The patent also highlights the importance of phospholipids in preventing and treating membrane-related disorders and diseases."

Problems solved by technology

This results in a variety of cognitive and mental disorders, such as depression, memory loss, short attention span, learning difficulties, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lipids containing omega-3 and omega-6 fatty acids
  • Lipids containing omega-3 and omega-6 fatty acids
  • Lipids containing omega-3 and omega-6 fatty acids

Examples

Experimental program
Comparison scheme
Effect test

example 1

Methods

Animals and Diet

[0144] Male Wistar rats originated from the same colonies were obtained from Harlen. Fifty rats were randomly divided into five dietary supplemented groups, in addition to their normal diet: (i) a group fed 0.1 g medium-chain triglycerides (MCT) / 1 ml supplement matrix (MCT group); (ii) a group fed 0.1 g DHA / EPA (20 / 30% of total fatty acids composition, diluted with MCT to generate 30% (w / w) LC-PUFA compound) triglycerides / 1 ml supplement matrix (LC-PUFA group); (iii) a group fed 0.1 g soybean lecithin-derived PS (20% SB-PS w / w) / 1 ml supplement matrix (SB-PS group); and (iv) a group fed 0.1 g PS- ω3 (20% PS w / w, and total LC-PUFA composition of 30%) / 1 ml supplement matrix (PS group). The supplement matrices were stored at −20° C., and fresh portions were fed to the rats every day. All supplements were handled so as to minimize oxidation of the fatty acids. Rats consumed the diet and water ad libitum. All rats were housed in a standard environment, in which t...

example 2

PS-omega-3 in the Treatment of ADHD Children

[0161] Attention-deficit / hyperactivity disorder (ADHD) encompasses a broad constellation of behavioural and learning problems and its definition and diagnosis remain controversial [Kamper (2001) J. Pediatr. 139:173-4; Richardson et al. (2000) Prostaglandins Leukot. Essent. Fatty Acids, 63(1-2):79-87]. The etiology of ADHD is acknowledged to be both complex and multi-factorial. Traditionally, ADHD is the diagnosis used to describe children who are inattentive, impulsive, and / or hyperactive. Roughly 20-25% of children with ADHD show one or more specific learning disabilities in math, reading, or spelling [Barkley, R. A. (1990) Attention-deficit hyperactivity disorder a handbook for diagnosis and treatment. New York: Guilford Press]. Children with ADHD often have trouble performing academically and paying attention, and may be disorganized, have poor self-discipline, and have low self-esteem. A conservative estimate is that 3-5% of the schoo...

example 3

Effect of PC-DHA Consumption in ApoE° Mice

Methods

Animal Diet

[0169] Apolipoprotein E deficient (ApoE°) mice [Hayek T. et al. (1994) Biochem. Biophys. Res. Commun. 201:1567-1574] at 8 weeks of age, were assigned randomly (5 mice each) to LC-PUFA enriched lecithin (30% omega-3 of total fatty acids composition; PC-DHA group) or placebo. The mice were fed, besides the regular chow diet, once every three days with either 25 μl PC-DHA or PBS, via oral gavage, during 10 weeks.

[0170] Each mouse consumed approximately 5 mL of water / day, and 5 g of chow / day.

Serum Lipids Peroxidation

[0171] Serum was diluted 1:4 in PBS. Serum susceptibility to oxidation was determined by incubating serum) sample with 110 mM of the free radical generating compound, 2′-2′-azobis 2′-amidinopropane hydrochloride (AAPH), which is an aqueous soluble azo compound that thermally decomposes to produce peroxyl radicals at a constant rate. The formation of thiobarbituric reactive substances (TBARS) and of lipid pe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Latency timeaaaaaaaaaa
temperatureaaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

A lipid preparation including a glycerophospholipid or salt, conjugate and derivatives thereof, particularly phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidyl-inositol (PI), phosphatidylglycerol (PG) and phosphatidic acid (PA), and poly-unsaturated fatty acid (PUFA) acyl groups, particularly long-chain poly-unsaturated fatty acid (LC-PUFA) acyl groups such as omega-3 and / or omega-6 acyl groups, wherein said PUFA is covalently bound to said glycerophospholipid. The preparation possesses an improved bioactivity, and is useful in the treatment of various cognitive and mental conditions and disorders and for maintenance of normal functions of brain-related systems and processes.

Description

RELATED APPLICATION [0001] The present application is a continuation of U.S. patent application Ser. No. 10 / 994,175, filed Nov. 19, 2004, which in turn is a continuation of International Patent Application No. PCT / IL2004 / 000957, filed Oct. 21, 2004, the contents of which are here incorporated by reference in their entirety.BACKGROUND OF THE INVENTION [0002] 1. Field of the Invention [0003] The present invention relates to phospholipids and polar lipids preparations which are enriched with omega-3 and / or omega-6 fatty acids covalently attached to the lipid backbone. The phospholipid preparations of the invention are particularly useful as nutraceuticals, food additives and / or pharmaceutical agents for the treatment of various conditions, in particular related to cognitive functions. [0004] 2. Prior Art [0005] Lipids, and especially polar lipids, nitrogen containing lipids, and carbohydrate containing lipids (phospholipids, sphingosines, glycolipids, ceramides, sphingomyelins) are the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/66A23D7/005A61K35/00A61K35/12A61K35/60A61K36/00A61K36/02A61P43/00A21D2/32A23D7/01A23D9/00A23D9/013A23L1/30A61K31/685
CPCA21D2/32A23D7/013A23D9/013A23L1/3008A23V2002/00A61K31/685A23V2200/322A23V2250/1882A23V2250/1942A23V2250/1842A23L33/12A61P25/00A61P43/00
Inventor DROR, GAI BENPLAT, DORITFARKASH, ORLYZUABI, RASSANBAR-ON, ZOHARSHULMAN, AVIDORPELLED, DORI
Owner ENZYMOTEC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com